JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M513105200 on August 1, 2006

J. Biol. Chem., Vol. 281, Issue 39, 29357-29368, September 29, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/39/29357    most recent
M513105200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, X.
Right arrow Articles by Xu, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, X.
Right arrow Articles by Xu, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Caspase-3-dependent Activation of Calcium-independent Phospholipase A2 Enhances Cell Migration in Non-apoptotic Ovarian Cancer Cells*

Xiaoxian Zhao{ddagger}, Dongmei Wang§, Zhenwen Zhao{ddagger}§, Yingyi Xiao{ddagger}, Saubhik Sengupta{ddagger}, Yijin Xiao{ddagger}, Renliang Zhang, Kirsten Lauber||, Sebastian Wesselborg||, Li Feng**, Tyler M. Rose**, Yue Shen{ddagger}{ddagger}, Junjie Zhang{ddagger}{ddagger}, Glenn Prestwich**, and Yan Xu{ddagger}§§§1

From the {ddagger}Department of Cancer Biology, The Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, §Department of Obstetrics and Gynecology, Indiana University, Indianapolis, Indiana 46202, Mass Spectrometry II Core, Cleveland Clinic, Cleveland, Ohio 44195, ||Department of Internal Medicine I, University of Tubingen, D-72076 Tubingen, Germany, **Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah 84108, {ddagger}{ddagger}National Institute of Biological Sciences, Beijing, 102206, China, and §§Department of Gynecology and Obstetrics, Cleveland Clinic, Cleveland, Ohio 44195

Calcium-independent phospholipase A2 (iPLA2) plays a pivotal role in phospholipid remodeling and many other biological processes, including inflammation and cancer development. iPLA2 can be activated by caspase-3 via a proteolytic process in apoptotic cells. In this study we identify novel signaling and functional loops of iPLA2 activation leading to migration of non-apoptotic human ovarian cancer cells. The extracellular matrix protein, laminin-10/11, but not collagen I, induces integrin- and caspase-3-dependent cleavage and activation of overexpressed and endogenous iPLA2. The truncated iPLA2 (amino acids 514-806) generates lysophosphatidic acid and arachidonic acid. Arachidonic acid is important for enhancing cell migration toward laminin-10/11. Lysophosphatidic acid activates Akt that in turn acts in a feedback loop to block the cleavage of poly-(ADP-ribose) polymerase and DNA fragmentation factor as well as prevent apoptosis. By using pharmacological inhibitors, blocking antibodies, and genetic approaches (such as point mutations, dominant negative forms of genes, and siRNAs against specific targets), we show that beta1, but not beta4, integrin is involved in iPLA2 activation and cell migration to laminin-10/11. The role of caspase-3 in iPLA2 activation and cell migration are supported by several lines of evidence. 1) Point mutation of Asp513 (a cleavage site of caspase-3 in iPLA2) to Ala blocks laminin-10/11-induced cleavage and activation of overexpressed iPLA2, whereas mutation of Asp733 to Ala has no such effect, 2) treatment of inhibitors or a small interfering RNA against caspase-3 results in decreased cell migration toward laminin-10/11, and 3) selective caspase-3 inhibitor blocks cleavage of endogenous iPLA2 induced by laminin-10/11. Importantly, small interfering RNA-mediated down-regulation of endogenous iPLA2 expression in ovarian carcinoma HEY cells results in decreased migration toward laminin, suggesting that our findings are pathophysiologically important.


Received for publication, December 8, 2005 , and in revised form, July 27, 2006.

* This work was supported in part by National Institutes of Health Grants RO1-CA89228 and RO1 CA095042 (to Y. X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Obstetrics and Gynecology, Indiana University, 975 W. Walnut St. IB355A, Indianapolis, IN 46202. Tel.: 317-274-3972; Fax: 317-278-2884; E-mail: xu2{at}iupui.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol Cancer ResHome page
G. Gdynia, K. Grund, A. Eckert, B. C. Bock, B. Funke, S. Macher-Goeppinger, S. Sieber, C. Herold-Mende, B. Wiestler, O. D. Wiestler, et al.
Basal Caspase Activity Promotes Migration and Invasiveness in Glioblastoma Cells
Mol. Cancer Res., December 1, 2007; 5(12): 1232 - 1240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Werner, F. Chen, J. V. Moyano, F. Yehiely, J. C. R. Jones, and V. L. Cryns
Caspase Proteolysis of the Integrin beta4 Subunit Disrupts Hemidesmosome Assembly, Promotes Apoptosis, and Inhibits Cell Migration
J. Biol. Chem., February 23, 2007; 282(8): 5560 - 5569.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.